retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports Retatrutide is a triple-agonist (GLP-1

Handling & storage Store the pen refrigerated at 28C, protect it from light, and keep it within the storage window printed on the COA

Period tracking apps (Clue, Flo, Apple Health) capture cycle length, flow heaviness, and PMS symptoms

What are the side effects of these drugs

Reviewed by Brandon Johnson Certified Personal Trainer, Nutrition Coach & Peptide Research Consultant Brandon Johnson is a certified personal trainer, nutrition coach, and peptide research consultant with a background in kinesiology and over 15 years of experience in fitness and wellness

If you have type 2 diabetes, work with a prescriber who can monitor HbA1c, fasting glucose, and post-prandial glucose throughout the titration

Initial results indicate that when comparing tirzepatide vs retatrutide, Retatrutide may lead to more substantial reductions in body mass, improving its efficacy in addressing obesity